Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Syncona (SYNC) Share Price

Price 122.00p on 25-09-2026 at 16:00:03
Change 4.20p 3.57%
Buy 122.00p
Sell 121.40p
Last Trade: Unknown 40,309.00 at 122.00p
Day's Volume: 5,496,911
Last Close: 122.00p
Open: 118.40p
ISIN: GG00B8P59C08
Day's Range 118.00p - 124.00p
52wk Range: 86.90p - 124.00p
Market Capitalisation: £742.01m
VWAP: 118.60331p
Shares in Issue: 608.20m

Syncona (SYNC) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 40,309 122.00p Ordinary
16:38:37 - 25-Sep-26
Buy* 36,023 122.00p Suspected BUY Trade
16:35:12 - 25-Sep-26
Buy* 818 121.982p Ordinary
16:29:28 - 25-Sep-26
Buy* 3,418 122.00p Automatic Execution
16:25:22 - 25-Sep-26
Buy* 10,000 121.94p Suspected BUY Trade
16:23:25 - 25-Sep-26
Sell* 22 121.576p Negotiated Trade
16:23:03 - 25-Sep-26
Buy* 2,352 121.957p SI Trade
16:21:22 - 25-Sep-26
Buy* 16,419 121.794p SI Trade
16:15:11 - 25-Sep-26
Sell* 29 121.40p SI Trade
16:06:22 - 25-Sep-26
Buy* 33,498 122.00p Ordinary
16:04:54 - 25-Sep-26
See more Syncona trades

Syncona (SYNC) Share Price History

Time period:
to
Date Open High Low Close Volume
24th Sep 2026 (Thu) 117.80 118.40 117.60 117.80 559,496
23rd Sep 2026 (Wed) 119.00 119.00 117.40 117.80 2,086,234
22nd Sep 2026 (Tue) 119.00 119.00 116.00 116.00 12,408,582
21st Sep 2026 (Mon) 114.20 120.20 114.20 117.40 35,993,657
18th Sep 2026 (Fri) 113.80 115.00 111.60 111.60 561,621
17th Sep 2026 (Thu) 112.00 112.00 111.60 111.80 245,813
16th Sep 2026 (Wed) 111.40 112.80 111.40 111.60 298,511
15th Sep 2026 (Tue) 113.80 113.80 112.40 113.60 34,069
14th Sep 2026 (Mon) 112.60 114.40 111.00 112.00 221,047
11th Sep 2026 (Fri) 111.20 112.60 111.20 112.60 103,134
10th Sep 2026 (Thu) 111.00 112.20 111.00 111.20 330,440
9th Sep 2026 (Wed) 111.00 111.20 111.00 111.00 434,677
8th Sep 2026 (Tue) 112.40 112.40 111.00 111.20 301,977
7th Sep 2026 (Mon) 114.80 114.80 112.40 113.00 335,271
4th Sep 2026 (Fri) 113.40 113.60 112.00 112.80 301,548
3rd Sep 2026 (Thu) 113.40 113.40 112.80 112.80 480,629
2nd Sep 2026 (Wed) 116.00 116.00 113.20 113.20 375,690
1st Sep 2026 (Tue) 117.00 117.00 113.40 113.40 427,425
31st Aug 2026 (Mon) 114.60 114.60 114.60 114.60 0
28th Aug 2026 (Fri) 116.00 117.00 114.60 114.60 981,236
27th Aug 2026 (Thu) 113.00 115.80 112.00 115.80 352,446
26th Aug 2026 (Wed) 112.00 113.00 110.80 113.00 301,867
25th Aug 2026 (Tue) 109.00 112.00 109.00 112.00 185,554
See more Syncona price history

Syncona (SYNC) Regulatory News

Date Source Headline
24th Sep 2026 12:00 pm RNS Holding(s) in Company
23rd Sep 2026 8:30 am RNS Holding(s) in Company
21st Sep 2026 7:00 am RNS Beacon delivers positive topline PII/III results
17th Sep 2026 4:30 pm RNS Holding(s) in Company
11th Sep 2026 3:15 pm RNS Holding(s) in Company
25th Aug 2026 5:15 pm RNS Holding(s) in Company
21st Aug 2026 8:00 am RNS Holding(s) in Company
18th Aug 2026 11:05 am RNS Result of AGM
6th Aug 2026 7:00 am RNS First Quarter Update
4th Aug 2026 2:00 pm RNS Holding(s) in Company
See more Syncona regulatory news

Syncona (SYNC) Share News

WINNERS & LOSERS: US-China optimism supports miners; Syncona up

21st Sep 2026 10:32

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Monday. Read More

IN BRIEF: Syncona says Beacon passes test in preventing vision loss

21st Sep 2026 08:58

Syncona Ltd - London-based life science investor - Portfolio holding Beacon Therapeutics Ltd's gene therapy laru-zova meets its primary endpoint in a phase II/III trial in treating the blinding condition X-linked retinitis pigmentosa. The endpoint, which was endorsed by the US Food & Drug Administration, was demonstrating statistically significant low luminesce visual acuity in patients at month 12, compared to a control group. XLRP is an inherited retinal disease that leads to progressive vision loss, moving from night blindness to being legally blind. Following the test results, Beacon plans a rolling biologics license application submission later this year. Read More

WINNERS & LOSERS: Vistry surges on UK government funding boost

25th Aug 2026 10:19

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Tuesday. Read More

UK shareholder meetings calendar - next 7 days

11th Aug 2026 13:48

Read More

FTSE 250 EARNINGS & UPDATES: TBC Bank profits from Georgian economy

6th Aug 2026 14:28

(Alliance News) - The following is a round-up of earnings and trading updates by FTSE 250-listed London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

See more Syncona news
FTSE 100 Latest
Value10,695.25
Change15.26

Login to your account

Forgot Password?

Not Registered